Study of a new infusion set for type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests a new device called a Photon Infusion Set that may make insulin delivery through your pump more effective. If you qualify, you may help us learn if this device is safe and works well for people with type 1 diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had type 1 diabetes for at least one year.
- You are between 18 and 80 years old.
- You use the MiniMed 780G insulin pump with a Guardian sensor.
- Your most recent A1c (average blood sugar over 3 months) is 10% or lower.
- You are not pregnant and not planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new automated insulin delivery system to help people with type 1 diabetes better manage their blood sugar. It aims to see if the system improves glucose control safely.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
This study tests whether an artificial intelligence (AI) system can help manage insulin pump therapy remotely for people with type 1 diabetes. The goal is to improve blood sugar control and make diabetes management easier.
This study tests a new experimental automated insulin delivery system for people with type 1 or type 2 diabetes who already use a specific insulin pump (MiniMed 780G with Simplera Sync sensor). The goal is to see if the new system is safe and works well to help manage blood sugar.
This study tests a new automated insulin delivery (AID) system that connects your insulin pump to your glucose monitor to help keep your blood sugar in range. It is for both children and adults with type 1 diabetes who have not used an AID system before.
This trial tests an oral medication that may help your body respond better to insulin. It's for people with type 1 diabetes who use an automated insulin pump and are willing to take a daily pill for 12 weeks.
Hear when a new Type 1 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.